X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1095) 1095
Book Review (298) 298
Publication (68) 68
Book / eBook (27) 27
Book Chapter (26) 26
Conference Proceeding (5) 5
Dissertation (3) 3
Data Set (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (988) 988
humans (693) 693
male (535) 535
animals (494) 494
neurosciences (485) 485
female (406) 406
parkinson's disease (349) 349
clinical neurology (315) 315
psychiatry (257) 257
dyskinesia, drug-induced - pathology (242) 242
levodopa - adverse effects (235) 235
rats (228) 228
dyskinesia, drug-induced - etiology (223) 223
middle aged (222) 222
dyskinesia (220) 220
dyskinesia, drug-induced - physiopathology (205) 205
basal ganglia (197) 197
movement disorders (197) 197
disease models, animal (188) 188
adult (184) 184
parkinson disease - drug therapy (183) 183
antiparkinson agents - adverse effects (174) 174
aged (171) 171
parkinsons-disease (171) 171
antipsychotic agents - adverse effects (169) 169
neurology (158) 158
pharmacology & pharmacy (154) 154
tardive-dyskinesia (154) 154
tardive dyskinesia (153) 153
dopamine (147) 147
schizophrenia (134) 134
schizophrenia - drug therapy (122) 122
rats, sprague-dawley (118) 118
dyskinesia, drug-induced - metabolism (117) 117
levodopa-induced dyskinesia (116) 116
levodopa (108) 108
dyskinesia, drug-induced - drug therapy (106) 106
analysis (99) 99
antipsychotic agents - therapeutic use (98) 98
dopa-induced dyskinesia (98) 98
l-dopa (97) 97
brain - pathology (93) 93
levodopa-induced dyskinesias (93) 93
neurons (93) 93
dyskinesia, drug-induced - diagnosis (92) 92
parkinson disease - physiopathology (91) 91
dopa (90) 90
corpus striatum - drug effects (89) 89
brain (85) 85
levodopa - therapeutic use (85) 85
corpus striatum - pathology (84) 84
dopamine - metabolism (83) 83
striatum (81) 81
time factors (80) 80
magnetic resonance imaging (78) 78
phenols (78) 78
abnormal involuntary movements (76) 76
antiparkinson agents - therapeutic use (76) 76
dose-response relationship, drug (76) 76
corpus striatum - metabolism (75) 75
mice (75) 75
parkinson disease - pathology (75) 75
parkinsonian disorders - drug therapy (73) 73
substantia-nigra (71) 71
brain - drug effects (68) 68
dyskinesias (66) 66
neurons - drug effects (66) 66
parkinson’s disease (66) 66
rat model (65) 65
motor activity - drug effects (64) 64
haloperidol (63) 63
abridged index medicus (60) 60
dystonia (57) 57
risk factors (56) 56
severity of illness index (56) 56
oxidopamine (55) 55
parkinsonian disorders - pathology (55) 55
parkinsons disease (54) 54
subthalamic nucleus (54) 54
neurons - pathology (53) 53
oxidopamine - toxicity (53) 53
research (53) 53
schizophrenic psychology (52) 52
neurons - metabolism (50) 50
rats, wistar (50) 50
treatment outcome (50) 50
substantia nigra - pathology (49) 49
behavior, animal - drug effects (48) 48
double-blind (48) 48
levodopa - pharmacology (48) 48
article (47) 47
neurodegenerative diseases (47) 47
dyskinesia, drug-induced - prevention & control (46) 46
medicine & public health (46) 46
care and treatment (45) 45
disease (45) 45
dyskinesia, drug-induced - complications (45) 45
nervous system diseases (45) 45
analysis of variance (44) 44
brain - metabolism (43) 43
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Providence Healthcare - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Missing (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Online Resources - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1120) 1120
French (4) 4
Japanese (4) 4
German (2) 2
Italian (2) 2
Russian (2) 2
Dutch (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological Psychiatry, ISSN 0006-3223, 2014, Volume 75, Issue 9, pp. 711 - 722
Background L-3,4-dihydroxyphenylalanine (L-DOPA)–induced dyskinesia is an incapacitating complication of L-DOPA therapy that affects most patients with... 
Psychiatry | three-dimensional neuronal reconstruction | medium spiny neuron | striatum | Behavioral sensitization | L-DOPA | dyskinesia | Parkinson’s disease | Parkinson's disease | RAT NEOSTRIATUM | HEMIPARKINSONIAN MICE | PSYCHIATRY | D-1 | NEUROSCIENCES | NUCLEUS-ACCUMBENS | DENDRITIC SPINES | LEVODOPA-INDUCED DYSKINESIA | STRIATAL NEURONS | EXPRESSION | PARKINSONS-DISEASE | Neurons - pathology | Dyskinesia, Drug-Induced - physiopathology | Cerebral Cortex - pathology | Male | Oxidopamine | Receptors, Dopamine D2 - metabolism | Cerebral Cortex - physiopathology | Receptors, Dopamine D1 - metabolism | Antiparkinson Agents - therapeutic use | Dendritic Spines - drug effects | Parkinsonian Disorders - drug therapy | Neurons - physiology | Receptors, Dopamine D1 - agonists | Cerebral Cortex - drug effects | Neurons - drug effects | Corpus Striatum - pathology | Membrane Potentials - drug effects | Dopamine Agonists - pharmacology | Parkinsonian Disorders - physiopathology | Corpus Striatum - physiopathology | Levodopa - therapeutic use | Mice, Inbred C57BL | Dendritic Spines - physiology | Proto-Oncogene Proteins c-fos - metabolism | Mice, Transgenic | Dyskinesia, Drug-Induced - pathology | Membrane Potentials - physiology | Antiparkinson Agents - adverse effects | Animals | Parkinsonian Disorders - pathology | Dendritic Spines - pathology | Levodopa - adverse effects | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology | Corpus Striatum - drug effects | Phenols | Dopamine | Dopa | Neurons | Movement disorders | Resveratrol | Index Medicus
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2009, Volume 34, Issue 2, pp. 279 - 290
Abstract The systemic rotenone model of Parkinson's disease (PD) accurately replicates many aspects of the pathology of human PD and has provided insights into... 
Neurology | Postural instability | Parkinson's disease | Dopamine | Behavior | Neurodegeneration | Rotenone | RISK-FACTORS | PROTECTION | RATS | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | NEUROTOXICITY | NEUROSCIENCES | DEGENERATION | 6-OHDA LESIONS | EXPOSURE | Substantia Nigra - physiopathology | Neurons - pathology | Tyrosine 3-Monooxygenase - metabolism | Dyskinesia, Drug-Induced - physiopathology | Substantia Nigra - pathology | Nerve Degeneration - physiopathology | Rats, Inbred Lew | Male | Hypokinesia - chemically induced | Nerve Degeneration - chemically induced | alpha-Synuclein - drug effects | Dopamine - deficiency | Muscle Rigidity - chemically induced | Rotenone - toxicity | Neurons - metabolism | Neurons - drug effects | Ubiquitins - metabolism | Disease Models, Animal | Parkinsonian Disorders - physiopathology | Reproducibility of Results | Injections, Intraperitoneal | Rats | Neurotoxins - toxicity | Parkinsonian Disorders - chemically induced | Tyrosine 3-Monooxygenase - drug effects | Dyskinesia, Drug-Induced - pathology | Nerve Degeneration - pathology | Uncoupling Agents - toxicity | Substantia Nigra - drug effects | Animals | Parkinsonian Disorders - pathology | Ubiquitins - drug effects | alpha-Synuclein - metabolism | Tyrosine | Analysis | Index Medicus | rotenone | neurodegeneration | postural instability | behavior | dopamine
Journal Article
Neuroscience, ISSN 0306-4522, 2015, Volume 310, pp. 12 - 26
Highlights • The neurotoxin 6-hydroxydopamine reduced tyrosine hydroxylase fibers in the primary motor cortex. • 6-Hydroxydopamine reduced basal norepinephrine... 
Neurology | l-DOPA | immediate-early gene | D1 agonist | dyskinesia | Parkinson’s disease | primary motor cortex | Primary motor cortex | agonist | Parkinson's disease | Immediate-early gene | L-DOPA | Dyskinesia | DOPA-INDUCED DYSKINESIA | LEVODOPA-INDUCED DYSKINESIAS | TYROSINE-HYDROXYLASE | 5-HT1A RECEPTOR STIMULATION | SYNAPTIC PLASTICITY | NEUROSCIENCES | PREFRONTAL CORTEX | HEMIPARKINSONIAN RATS | PYRAMIDAL NEURONS | TRANSCRANIAL MAGNETIC STIMULATION | NOREPINEPHRINE TRANSPORTER | D-1 agonist | Synaptic Transmission - physiology | Gene Expression - drug effects | Benzazepines - adverse effects | Male | Dopamine Agents - adverse effects | Motor Cortex - metabolism | Parkinsonian Disorders - drug therapy | Gene Expression - physiology | Functional Laterality - drug effects | Synaptic Transmission - drug effects | Medial Forebrain Bundle - injuries | Disease Models, Animal | Dyskinesia, Drug-Induced - etiology | Severity of Illness Index | AIDS-Related Complex - metabolism | Levodopa - therapeutic use | Proto-Oncogene Proteins c-fos - metabolism | Rats | Parkinsonian Disorders - chemically induced | Dyskinesia, Drug-Induced - pathology | Rats, Sprague-Dawley | Oxidopamine - toxicity | Animals | Proto-Oncogene Proteins c-fos - genetics | AIDS-Related Complex - genetics | Drug therapy | Gene expression | Genes | Movement disorders | Antiparkinsonian agents | Index Medicus | Primary Motor Cortex | Parkinson’s Disease | Immediate-early Gene | D1 Agonist
Journal Article
Journal Article
Annals of Neurology, ISSN 0364-5134, 11/2010, Volume 68, Issue 5, pp. 619 - 628
Journal Article
Journal Article
British Journal of Psychiatry, ISSN 0007-1250, 07/2013, Volume 203, Issue 1, pp. 6 - 7
Sarro et al report grey matter deficits associated with tardive dyskinesia in schizophrenia. Much evidence suggests that the intrinsic pathophysiology of... 
PSYCHIATRY | RISK-FACTORS | Movement Disorders - pathology | Humans | Brain - pathology | Female | Male | Schizophrenia - pathology | Dyskinesia, Drug-Induced - pathology | Index Medicus
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 10/2007, Volume 32, Issue 10, pp. 2229 - 2237
Journal Article
Experimental Neurology, ISSN 0014-4886, 11/2017, Volume 297, pp. 73 - 81
Journal Article